Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Major depressive episode diagnosed with Diagnostic and Statistical Manual Diploma in Social Medicine-IV (DSM-IV)~* Hamilton Depression Scale (HAMD-17) ≥ 14~Exclusion Criteria:~* Any other axis I primary diagnoses except major depressive disorder~* Having serious adverse events or hypersensitivity to mirtazapine~* Having major depressive disorder prior to the first injection of interferon

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- mirtazapine (Type: EXPERIMENTAL): mirtazapine
- Supportive psychotherapy (Type: OTHER): Supportive psychotherapy will be given by a specialized psychiatrist.

Based on this trial design, predict the completion outcome and termination type (if applicable).